Revolution Medicines, Inc.RVMDNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-19.10%
↓ 39% below average
Average (27q)
-13.76%
Historical baseline
Range
High:21.74%
Low:-46.03%
Volatility
-492.6%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -19.10% |
| Q2 2025 | -9.95% |
| Q1 2025 | -11.30% |
| Q4 2024 | -23.10% |
| Q3 2024 | -12.17% |
| Q2 2024 | -11.21% |
| Q1 2024 | 21.74% |
| Q4 2023 | -46.03% |
| Q3 2023 | -13.28% |
| Q2 2023 | -44.76% |
| Q1 2023 | -21.80% |
| Q4 2022 | 19.37% |
| Q3 2022 | -23.26% |
| Q2 2022 | -7.14% |
| Q1 2022 | -9.52% |
| Q4 2021 | 0.47% |
| Q3 2021 | -19.37% |
| Q2 2021 | -19.09% |
| Q1 2021 | -9.73% |
| Q4 2020 | -23.70% |
| Q3 2020 | 1.55% |
| Q2 2020 | -32.74% |
| Q1 2020 | -7.76% |
| Q4 2019 | -44.29% |
| Q3 2019 | -28.39% |
| Q2 2019 | -1.20% |
| Q1 2019 | 10.57% |
| Q4 2018 | 0.00% |